These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 19640250

  • 1. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y, Zhu J, Tang Y, Chen X, Yang Y.
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [Abstract] [Full Text] [Related]

  • 2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.
    Chen XJ, Zhu JB, Wang GJ, Zhou MX, Xin FM, Zhang N, Wang CX, Xu YN.
    Acta Pharmacol Sin; 2002 May; 23(5):467-70. PubMed ID: 11978199
    [Abstract] [Full Text] [Related]

  • 4. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C, Müller BW, Steckel H.
    Int J Pharm; 2009 Jul 30; 377(1-2):173-9. PubMed ID: 19446621
    [Abstract] [Full Text] [Related]

  • 5. Deposition of insulin powders for inhalation in vitro and pharmacodynamic evaluation of absorption promoters in rats.
    Yang DB, Zhu JB, Zhu H, Zhang XS.
    Yao Xue Xue Bao; 2005 Dec 30; 40(12):1069-74. PubMed ID: 16496667
    [Abstract] [Full Text] [Related]

  • 6. Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.
    Onoue S, Yamamoto K, Kawabata Y, Hirose M, Mizumoto T, Yamada S.
    Int J Pharm; 2009 Dec 01; 382(1-2):144-50. PubMed ID: 19703531
    [Abstract] [Full Text] [Related]

  • 7. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
    Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C.
    J Control Release; 2012 Feb 10; 157(3):383-90. PubMed ID: 21864592
    [Abstract] [Full Text] [Related]

  • 8. Microencapsulated chitosan nanoparticles for lung protein delivery.
    Grenha A, Seijo B, Remuñán-López C.
    Eur J Pharm Sci; 2005 Feb 10; 25(4-5):427-37. PubMed ID: 15893461
    [Abstract] [Full Text] [Related]

  • 9. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
    Shen ZG, Chen WH, Jugade N, Gao LY, Glover W, Shen JY, Yun J, Chen JF.
    Int J Pharm; 2012 Jul 01; 430(1-2):98-103. PubMed ID: 22486960
    [Abstract] [Full Text] [Related]

  • 10. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS, Ramakrishna S, Saini TR, Diwan PV.
    Pharmazie; 2006 Jul 01; 61(7):613-7. PubMed ID: 16889069
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 12. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 13. Solid lipid nanoparticles for pulmonary delivery of insulin.
    Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z.
    Int J Pharm; 2008 May 22; 356(1-2):333-44. PubMed ID: 18281169
    [Abstract] [Full Text] [Related]

  • 14. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC, Levy HV, Botner S.
    J Control Release; 2010 Dec 01; 148(2):168-76. PubMed ID: 20709120
    [Abstract] [Full Text] [Related]

  • 15. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
    Lebhardt T, Roesler S, Uusitalo HP, Kissel T.
    Eur J Pharm Biopharm; 2011 May 01; 78(1):90-6. PubMed ID: 21145394
    [Abstract] [Full Text] [Related]

  • 16. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY, Seville PC, Williamson IJ, Birchall JC.
    J Gene Med; 2005 Aug 01; 7(8):1035-43. PubMed ID: 15756712
    [Abstract] [Full Text] [Related]

  • 17. Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.
    Ji Y, Liu C, Pei YY.
    Acta Pharmacol Sin; 2007 May 01; 28(5):744-50. PubMed ID: 17439732
    [Abstract] [Full Text] [Related]

  • 18. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS, Abnous K, Tafaghodi M.
    Int J Pharm; 2014 Apr 25; 465(1-2):464-78. PubMed ID: 24560646
    [Abstract] [Full Text] [Related]

  • 19. Effervescent dry powder for respiratory drug delivery.
    Ely L, Roa W, Finlay WH, Löbenberg R.
    Eur J Pharm Biopharm; 2007 Mar 25; 65(3):346-53. PubMed ID: 17156987
    [Abstract] [Full Text] [Related]

  • 20. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
    Zhao YZ, Li X, Lu CT, Xu YY, Lv HF, Dai DD, Zhang L, Sun CZ, Yang W, Li XK, Zhao YP, Fu HX, Cai L, Lin M, Chen LJ, Zhang M.
    Acta Diabetol; 2012 Aug 25; 49(4):315-25. PubMed ID: 22124766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.